Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Quaratusugene Ozeplasmid |
| Trade Name | |
| Synonyms | GPX-001|DOTAP:cholesterol-Fus1 liposome complex|INGN 401|DOTAP:chol-Fus1 |
| Drug Descriptions |
Quaratusugene Ozeplasmid is a complex of liposomal nanoparticles with a plasmid expression cassette encoding the human FUS1 protein, which may lead to induction of tumor cell apoptosis and suppression of tumor cell proliferation (PMID: 15486560). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C91708 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + Quaratusugene Ozeplasmid | Atezolizumab Quaratusugene Ozeplasmid | 0 | 1 |
| Osimertinib + Quaratusugene Ozeplasmid | Osimertinib Quaratusugene Ozeplasmid | 0 | 1 |
| Pembrolizumab + Quaratusugene Ozeplasmid | Pembrolizumab Quaratusugene Ozeplasmid | 0 | 1 |
| Quaratusugene Ozeplasmid | Quaratusugene Ozeplasmid | 0 | 1 |